SRx Health Solutions updates portfolio strategy, reducing Compass and Bitcoin positions while investing in Uber and enhancing risk management.
Quiver AI Summary
SRx Health Solutions, Inc. announced an update on its investment portfolio, revealing a new position in Uber Technologies, Inc. while reducing its long position in Compass and diminishing its short exposure to Bitcoin. These strategic adjustments are part of a more conservative investment approach following a negative shift in the EMJX stress model, indicating increased market stress for the first time since April 2026. Eric Jackson, Founder of EMJX, emphasized the importance of risk management in the current market environment. The company is actively managing its portfolio to balance growth and risk, with further details provided in a Registration Statement filed with the SEC concerning the proposed merger with EMJ Crypto Technologies. Investors are encouraged to review all relevant documents related to the merger for important information.
Potential Positives
- Initiated a position in Uber Technologies, Inc., reflecting a strategic repositioning toward high-conviction assets.
- Reduced long position in Compass, showing a proactive approach to portfolio management amidst changing market conditions.
- Transition of the EMJX stress model to STRESS indicates a focus on disciplined risk management to protect capital.
- Merger agreement with EMJ Crypto Technologies suggests potential for growth and innovation in digital asset management.
Potential Negatives
- Reduction of the long position in Compass, Inc. could signal a lack of confidence in that investment strategy, raising concerns among stakeholders about the company's commitment to its portfolio.
- The EMJX stress model shifting from MIXED to STRESS indicates heightened market risks, marking the first negative market reading since April 2026, which could prompt investor apprehension regarding the company's future performance.
- The focus on defensive risk management may imply that the company is anticipating market instability, potentially reflecting negatively on its growth prospects and overall strategy.
FAQ
What changes has SRx Health Solutions made to its investment portfolio?
SRx Health Solutions has reduced its long position in Compass, trimmed short exposure to Bitcoin, and initiated an investment in Uber Technologies.
What does the EMJX stress model indicate?
This week, the EMJX stress model shifted to STRESS from MIXED, indicating the first negative market reading since April 4, 2026.
How is SRx Health Solutions managing risk in its portfolio?
SRx Health Solutions is adopting a cautious posture, layering in selective hedges and focusing on disciplined risk management.
What is the purpose of the SEC Registration Statement filed by SRx Health Solutions?
The Registration Statement is to register the common stock to be issued in connection with the proposed transaction between SRx Health and EMJX.
Are the statements in the press release forward-looking?
Yes, the press release includes forward-looking statements which are subject to risks and uncertainties that could affect actual results.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$SRXH Revenue
$SRXH had revenues of $2.8M in Q1 2026. This is a decrease of -60.79% from the same period in the prior year.
You can track SRXH financials on Quiver Quantitative's SRXH stock page.
You can access data on SRXH stock through the Quiver Quantitative API.
$SRXH Hedge Fund Activity
We have seen 14 institutional investors add shares of $SRXH stock to their portfolio, and 11 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- JANE STREET GROUP, LLC added 595,228 shares (+inf%) to their portfolio in Q1 2026, for an estimated $76,784
- TWO SIGMA SECURITIES, LLC added 195,220 shares (+inf%) to their portfolio in Q1 2026, for an estimated $25,183
- GEODE CAPITAL MANAGEMENT, LLC added 132,777 shares (+115.8%) to their portfolio in Q1 2026, for an estimated $17,128
- VANGUARD GROUP INC added 124,006 shares (+79.1%) to their portfolio in Q4 2025, for an estimated $28,298
- SCOTIA CAPITAL INC. added 90,132 shares (+500.7%) to their portfolio in Q1 2026, for an estimated $11,627
- XTX TOPCO LTD added 73,290 shares (+inf%) to their portfolio in Q1 2026, for an estimated $9,454
- NORTHERN TRUST CORP removed 46,238 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $5,964
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
Full Release
Reduced long position in Compass, Inc., reduced short exposure to Bitcoin and added selective hedges in select international markets
EMJX stress model turned STRESS from MIXED this week – the first negative market reading since the bull rotation beginning on April 4, 2026
NORTH PALM BEACH, Fla., May 29, 2026 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE American: SRXH) (the "Company") and EMJ Crypto Technologies ("EMJX"), a digital-asset treasury operating platform with which the Company has entered into a definitive merger agreement, today provided an update on its portfolio, including the initiation of an investment in Uber Technologies, Inc.
"This week, we initiated a position in Uber Technologies as part of our repositioning across select, high-conviction assets within our portfolio," said Michael Young, Board Member at SRx Health Solutions. "We've reduced our long position in Compass, trimmed our short exposure to Bitcoin, and layered in selective hedges across a few international markets. These moves reflect a more cautious posture, as our EMJX stress model has shifted to STRESS from MIXED this week, the first negative market reading we've seen since the bull rotation on April 4, 2026, and we're managing the book accordingly."
"Our job isn't to predict the market — it's to respect it. When the model turns to STRESS, that's the signal to lead with risk management and protect capital before the risk shows up in prices. Acting early and defensively every time the regime turns is the discipline we're building this Gen2 EMJX platform on." — Eric Jackson, Founder of EMJX.
SRx Health Solutions and EMJX continue to actively manage the portfolio with an emphasis on balancing growth opportunities against disciplined risk management.
Additional Information and Where to Find It
In connection with the proposed transaction between the Company has filed with the SEC a Registration Statement on Form S-4 (the "Registration Statement") to register the common stock to be issued in connection with the proposed transaction. The Registration Statement includes an information statement of the Company and a prospectus of the Company (the "Information Statement/Prospectus"), and each of EMJX and the Company may file with the SEC other relevant documents concerning the proposed transaction. After the Registration Statement is declared effective, the definitive Information Statement/Prospectus will be sent to the stockholders This is not a substitute for the Registration Statement, the Information Statement/Prospectus or any other relevant documents that EMJX or the Company has filed or will file with the SEC. BEFORE MAKING ANY INVESTMENT DECISION, INVESTORS AND STOCKHOLDERS OF THE COMPANY ARE URGED TO CAREFULLY AND ENTIRELY READ THE REGISTRATION STATEMENT AND INFORMATION STATEMENT/PROSPECTUS REGARDING THE PROPOSED TRANSACTION AND ANY OTHER RELEVANT DOCUMENTS, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO THOSE DOCUMENTS, IF AND WHEN THEY BECOME AVAILABLE, BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT EMJX, THE COMPANY, THE PROPOSED TRANSACTION, AND RELATED MATTERS. A copy of the Registration Statement, Information Statement/Prospectus, as well as other relevant documents filed by EMJX and the Company with the SEC, may be obtained free of charge, when they become available, at the SEC's website at www.sec.gov. The information on EMJX's or the Company's respective websites is not, and shall not be deemed to be, a part of this communication or incorporated into other filings either company makes with the SEC.
No Offer or Solicitation
This communication is for informational purposes only and is not intended to and does not constitute an offer to sell or the solicitation of an offer to buy or sell any securities or the solicitation of any proxy, vote or approval, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act, or in a transaction exempt from the registration requirements of the Securities Act.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as "believe," "expect," "intend," "aim," "plan," "may," "could," "target," and similar expressions are intended to identify forward-looking statements. These statements are based on current expectations and assumptions that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied. These risks include, but are not limited to, the ability to complete the proposed transaction, shareholder approvals, market conditions, regulatory considerations, and other risks described in the Company's filings with the Securities and Exchange Commission. Forward-looking statements speak only as of the date made, and the Company undertakes no obligation to update them, except as required by law.
Company Contact
SRx Health Solutions, Inc.
Kent Cunningham, Chief Executive Officer
Investor Relations Contact
KCSA Strategic Communications
Valter Pinto, Managing Director
212-896-1254
[email protected]